The National Pharmaceutical Council is an American health policy research organization that lobbies the U.S. Government to further support medical innovation.
NPC was founded in 1953 with support from the nation’s major research-based biopharmaceutical companies.1)
Members of the NPC include AbbVie, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Genentech, Gilead Sciences, Horizon Therapeutics, Johnson & Johnson, Mallinckrodt, Merck, Novartis, Pfizer, Sarepta Therapautics, Spark Therapeutics, Takeda, and UCB.2)